The Akt-Specific Inhibitor MK2206 Selectively Inhibits Thyroid Cancer Cells Harboring Mutations That Can Activate the PI3K/Akt PathwayRuixin Liu, Mingzhao Xing|The Journal of Clinical Endocrinology & Metabolism|2011Cited by 105
Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitisYanru Ma, Jie Hong, Baoqin Xuan et al.|Gut|2023Cited by 51